ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 303 filers reported holding ALKERMES PLC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $170,622,747 | -7.5% | 6,091,494 | +3.4% | 0.01% | -10.0% |
| Q2 2023 | $184,366,484 | +13.0% | 5,890,303 | +1.8% | 0.01% | +11.1% |
| Q1 2023 | $163,136,686 | -51.7% | 5,787,041 | -55.2% | 0.01% | -10.0% |
| Q4 2022 | $337,568,610 | +133.8% | 12,918,814 | +99.8% | 0.01% | +11.1% |
| Q3 2022 | $144,413,000 | -18.0% | 6,467,201 | +9.4% | 0.01% | -18.2% |
| Q2 2022 | $176,092,000 | +15.8% | 5,911,104 | +2.3% | 0.01% | +37.5% |
| Q1 2022 | $152,069,000 | +14.8% | 5,779,899 | +1.5% | 0.01% | +33.3% |
| Q4 2021 | $132,453,000 | -12.7% | 5,694,440 | +15.7% | 0.01% | -25.0% |
| Q3 2021 | $151,778,000 | +24.9% | 4,921,476 | -0.7% | 0.01% | +33.3% |
| Q2 2021 | $121,480,000 | +44.7% | 4,954,336 | +10.2% | 0.01% | +20.0% |
| Q1 2021 | $83,959,000 | -13.4% | 4,494,601 | -7.6% | 0.01% | -16.7% |
| Q4 2020 | $97,005,000 | +24.6% | 4,862,428 | +3.5% | 0.01% | +20.0% |
| Q3 2020 | $77,858,000 | -23.0% | 4,698,739 | -9.8% | 0.01% | -28.6% |
| Q2 2020 | $101,074,000 | +47.9% | 5,208,665 | +9.9% | 0.01% | +16.7% |
| Q1 2020 | $68,319,000 | -28.0% | 4,737,799 | +1.9% | 0.01% | 0.0% |
| Q4 2019 | $94,878,000 | -8.6% | 4,650,861 | -12.6% | 0.01% | -25.0% |
| Q3 2019 | $103,836,000 | -22.2% | 5,322,208 | -10.1% | 0.01% | -20.0% |
| Q2 2019 | $133,437,000 | -26.6% | 5,920,002 | +18.8% | 0.01% | -28.6% |
| Q1 2019 | $181,764,000 | +34.3% | 4,981,207 | +8.6% | 0.01% | +16.7% |
| Q4 2018 | $135,334,000 | -30.2% | 4,586,039 | +0.4% | 0.01% | -20.0% |
| Q3 2018 | $193,891,000 | +14.4% | 4,568,588 | +10.9% | 0.02% | +7.1% |
| Q2 2018 | $169,505,000 | -27.5% | 4,118,056 | +2.2% | 0.01% | -30.0% |
| Q1 2018 | $233,647,000 | +5.8% | 4,031,142 | -0.1% | 0.02% | +11.1% |
| Q4 2017 | $220,881,000 | -0.5% | 4,035,850 | -7.6% | 0.02% | -5.3% |
| Q3 2017 | $221,970,000 | -2.7% | 4,365,909 | +11.0% | 0.02% | -5.0% |
| Q2 2017 | $228,106,000 | -1.9% | 3,934,797 | -1.0% | 0.02% | -4.8% |
| Q1 2017 | $232,480,000 | +11.7% | 3,974,002 | +6.1% | 0.02% | +5.0% |
| Q4 2016 | $208,160,000 | +20.6% | 3,745,283 | +2.0% | 0.02% | +17.6% |
| Q3 2016 | $172,635,000 | +8.4% | 3,670,783 | -0.3% | 0.02% | 0.0% |
| Q2 2016 | $159,219,000 | +25.0% | 3,683,632 | -1.2% | 0.02% | +21.4% |
| Q1 2016 | $127,418,000 | -46.6% | 3,726,611 | +24.0% | 0.01% | -46.2% |
| Q4 2015 | $238,600,000 | +41.2% | 3,005,724 | +4.4% | 0.03% | +30.0% |
| Q3 2015 | $168,947,000 | -3.3% | 2,879,727 | +6.0% | 0.02% | +5.3% |
| Q2 2015 | $174,790,000 | +11.7% | 2,716,706 | +5.8% | 0.02% | +18.8% |
| Q1 2015 | $156,502,000 | +47.5% | 2,566,866 | +41.7% | 0.02% | +45.5% |
| Q4 2014 | $106,086,000 | +32.9% | 1,811,578 | -2.7% | 0.01% | +22.2% |
| Q3 2014 | $79,804,000 | -12.8% | 1,861,517 | +2.4% | 0.01% | -10.0% |
| Q2 2014 | $91,477,000 | +12.2% | 1,817,582 | -1.7% | 0.01% | +11.1% |
| Q1 2014 | $81,529,000 | -39.7% | 1,849,213 | -64.5% | 0.01% | 0.0% |
| Q4 2013 | $135,140,000 | +103.2% | 5,214,226 | +163.6% | 0.01% | +12.5% |
| Q3 2013 | $66,491,000 | +14.9% | 1,977,730 | -2.0% | 0.01% | 0.0% |
| Q2 2013 | $57,890,000 | – | 2,018,498 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,950,000 | $148,506,000 | 14.24% |
| Krensavage Asset Management, LLC | 1,627,323 | $30,398,000 | 10.52% |
| Healthcare Value Capital, LLC | 100,000 | $1,868,000 | 4.16% |
| Camber Capital Management LP | 5,600,000 | $104,608,000 | 3.59% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $65,828,000 | 1.51% |
| CM Management, LLC | 70,000 | $1,308,000 | 0.97% |
| PRICE MICHAEL F | 305,000 | $5,697,000 | 0.68% |
| Palo Alto Investors LP | 487,100 | $9,099,000 | 0.52% |
| SEIZERT CAPITAL PARTNERS, LLC | 463,600 | $8,660,000 | 0.45% |
| Birchview Capital, LP | 35,000 | $654,000 | 0.39% |